Godsey & Gibb Inc’s Organon & Co OGN Stock Holding History

Godsey & Gibb Inc’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$6	–	398
2026 Q1	$6	Hold	1	–	–	﹤0.01%	387
2025 Q4	$8	Hold	1	–	–	﹤0.01%	437
2025 Q3	$11	Hold	1	–	–	﹤0.01%	374
2025 Q2	$10	Hold	1	–	–	﹤0.01%	353
2025 Q1	$15	Hold	1	–	–	﹤0.01%	387
2024 Q4	$15	Hold	1	–	–	﹤0.01%	367
2024 Q3	$20	Hold	1	–	–	﹤0.01%	428
2024 Q2	$21	Hold	1	–	–	﹤0.01%	398
2024 Q1	$19	Hold	1	–	–	﹤0.01%	380
2023 Q4	$15	Sell	1 -10	-91%	-$136	﹤0.01%	355
2023 Q3	$191	Buy	11 +10	+1,000%	+$209	﹤0.01%	330
2023 Q2	$21	Hold	1	–	–	﹤0.01%	363
2023 Q1	$24	Sell	1 -52	-98%	-$1.4K	﹤0.01%	333
2022 Q4	$1.48K	Buy	53 +52	+5,200%	+$1.33K	﹤0.01%	273
2022 Q3	$0	Buy	+1	New	+$30	﹤0.01%	137
2022 Q2	–	Sell	-201	Closed	-$7K	–	152
2022 Q1	$7K	Buy	+201	New	+$6.87K	﹤0.01%	90

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Godsey & Gibb Inc's OGN Position: Q2 2026 in Review

Godsey & Gibb Inc sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 1 share — an estimated $6 sold.

Godsey & Gibb Inc first reported a position in OGN in Q1 2022 and held it in 16 quarters. The position peaked at $7K in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Godsey & Gibb Inc reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Godsey & Gibb Inc sold 1 Organon & Co share in Q2 2026, an estimated $6.
Godsey & Gibb Inc first reported a position in Organon & Co in Q1 2022 and held it in 16 quarters.
Godsey & Gibb Inc's Organon & Co position peaked at $7K in Q1 2022.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.